20 articles
New guidance suggests mothers taking bempedoic acid for cholesterol need not stop breastfeeding, though caution is advised for newborns.
Beta-hydroxybutyrate restores AMPA receptor function and prevents memory loss triggered by saturated fat-rich diets in mice.
Baxdrostat blocks aldosterone production directly, cutting systolic BP by ~15 mmHg in resistant hypertension patients who failed other drugs.
A natural alkaloid from traditional Chinese medicine activates a key bile acid receptor to restore intestinal balance and reduce colitis inflammation.
A comprehensive review argues that BPC 157's effects on angiogenesis and nitric oxide are therapeutic assets, not risks, with anti-tumor and neuroprotective evidence.
Researchers rebut claims that BPC 157 promotes tumor growth or neurodegeneration, citing evidence it modulates—not dysregulates—angiogenesis and NO.
AstraZeneca's BAXFENDY cuts systolic blood pressure by nearly 10 mmHg beyond placebo in adults whose BP wasn't controlled by other drugs.
FDA-approved methylene blue reduced delirium-like behavior in surgical mice by suppressing neuroinflammation and repairing the blood-brain barrier.
Combining two traditional herbal compounds fixes a dangerous liver toxicity problem while making colitis treatment significantly more effective.
Modified antioxidant shows promise for preventing diabetic retinopathy and macular degeneration by boosting cellular protection.
A comprehensive review reveals methylene blue's expanding role from toxicology emergencies to perioperative care, neurology, and oncology.
A bile acid found in blood predicts and treats obesity-induced endothelial dysfunction through a newly discovered FXR-ATF4 metabolic axis.
A gut-derived metabolite called phenylacetic acid rises with age and causes blood vessel cells to senesce, linking the microbiome to cardiovascular aging.
A stable gastric peptide called BPC 157 may offer bidirectional vascular protection, countering both hemorrhage and thrombosis without disrupting coagulation.
A new rodent study finds that beta-hydroxybutyrate salt reduces alcohol consumption in both sexes and alters dopamine signaling in the brain's reward center.
Betulinic acid from birch bark significantly reduced arterial stiffness and cellular aging markers in both lab and animal studies.
Buddleoside activates AMPK, suppresses MTORC1, and restores autophagy to combat nonalcoholic steatohepatitis in mice.
Commentary examines the therapeutic potential of BPC-157, a natural 15-amino acid peptide with remarkable cytoprotective properties.
Reverse network pharmacology pinpoints berberine as a promising treatment for CKM syndrome, validated in a novel mouse model combining metabolic and cardiac stress.
ATX-304 raised resting metabolic rate 8%, slashed triglycerides, and reduced liver fat in an 8-week Phase 1b trial for prediabetes.
